Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees

The sensitivity of the BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (BinaxNOW) was 51.6% among asymptomatic healthcare employees relative to real-time reverse transcriptase polymerase chain reaction (rRT-PCR). The odds of a positive BinaxNOW test decreased as cycle threshold value incre...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Allison E., Gulley, Trent, Kothari, Atul, Holder, Kasey, Garner, Kelley, Patil, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870908/
https://www.ncbi.nlm.nih.gov/pubmed/33487197
http://dx.doi.org/10.1017/ice.2021.20
_version_ 1783648904372289536
author James, Allison E.
Gulley, Trent
Kothari, Atul
Holder, Kasey
Garner, Kelley
Patil, Naveen
author_facet James, Allison E.
Gulley, Trent
Kothari, Atul
Holder, Kasey
Garner, Kelley
Patil, Naveen
author_sort James, Allison E.
collection PubMed
description The sensitivity of the BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (BinaxNOW) was 51.6% among asymptomatic healthcare employees relative to real-time reverse transcriptase polymerase chain reaction (rRT-PCR). The odds of a positive BinaxNOW test decreased as cycle threshold value increased. BinaxNOW could facilitate rapid detection and isolation of asymptomatically infected persons in some settings while rRT-PCR results are pending.
format Online
Article
Text
id pubmed-7870908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-78709082021-02-09 Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees James, Allison E. Gulley, Trent Kothari, Atul Holder, Kasey Garner, Kelley Patil, Naveen Infect Control Hosp Epidemiol Concise Communication The sensitivity of the BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (BinaxNOW) was 51.6% among asymptomatic healthcare employees relative to real-time reverse transcriptase polymerase chain reaction (rRT-PCR). The odds of a positive BinaxNOW test decreased as cycle threshold value increased. BinaxNOW could facilitate rapid detection and isolation of asymptomatically infected persons in some settings while rRT-PCR results are pending. Cambridge University Press 2021-01-25 /pmc/articles/PMC7870908/ /pubmed/33487197 http://dx.doi.org/10.1017/ice.2021.20 Text en © The Society for Healthcare Epidemiology of America 2021 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Concise Communication
James, Allison E.
Gulley, Trent
Kothari, Atul
Holder, Kasey
Garner, Kelley
Patil, Naveen
Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title_full Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title_fullStr Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title_full_unstemmed Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title_short Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
title_sort performance of the binaxnow coronavirus disease 2019 (covid-19) antigen card test relative to the severe acute respiratory coronavirus virus 2 (sars-cov-2) real-time reverse transcriptase polymerase chain reaction (rrt-pcr) assay among symptomatic and asymptomatic healthcare employees
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870908/
https://www.ncbi.nlm.nih.gov/pubmed/33487197
http://dx.doi.org/10.1017/ice.2021.20
work_keys_str_mv AT jamesallisone performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees
AT gulleytrent performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees
AT kothariatul performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees
AT holderkasey performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees
AT garnerkelley performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees
AT patilnaveen performanceofthebinaxnowcoronavirusdisease2019covid19antigencardtestrelativetothesevereacuterespiratorycoronavirusvirus2sarscov2realtimereversetranscriptasepolymerasechainreactionrrtpcrassayamongsymptomaticandasymptomatichealthcareemployees

Ejemplares similares